Abstract:Objective To investigate the expression of Wntless (WLS) in non-special type of invasive ductal carcinoma (IDC-NOS) of breast and its significance. Methods Ten normal breast tissue and 179 patients' breast tumor samples diagnosed as IDC-NOS from Jan. 2005 to Dec. 2012 were collected. Estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor recepter2 (HER-2), Ki-67 and WLS expressions were assessed by immunohistochemistry. The clinicopathologic characteristics, including age, menstrual status, clinical stage, recurrence, metastasis and death were recorded. All these data were retrospectively analyzed by SPSS statistical analysis system. Results Level of WLS expression in IDC-NOS was significantly different with that in normal breast tissue (P<0.01). Lymph node metastasis and expression of ER was correlated with WLS expression (P<0.05). Spearman's rank correlation analysis indicated that WLS expression were negatively correlated with ER expression (P<0.05), and no correlation with age, menstrual status, tumor size, tumor location, tumor histological grade, vascular invasion, lymph node metastasis and clinical stage was seen (P>0.05). Kaplan-Meier survival analysis indicated that negative expression of WLS had a trend to recur (P=0.085) and was associated with shorter survival (P<0.01). Univariate and multivariate analysis of variance and regression analysis suggested that positive expression of WLS were a better prognosis factor (P<0.01). Conclusions WLS might be closely related with occurrence, development and prognosis of IDC-NOS. Furthermore, WLS might be a potential indicator in the treatment of breast cancer. However, the relevant mechanism remaines unclear and more insight are needed for further analyzing the mechanism of WLS in IDC-NOS.

Expression of WWOX in tissues of breast cancer and its association with ER and menopausal status

Expression of WWOX Protein in Non-Small Cell Lung Cancer and Its Significance

Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer.

Expression of WWOX in Hepatocellular Carcinoma and Resection Margin

The expression of 5-LOX in epithelial ovarian carcinoma and its significance

The downregulation of WWOX induces epithelial-mesenchymal transition and enhances stemness and chemoresistance in breast cancer.

Update of the WWOX tumor suppressor gene

Loss of WWOX expression in human extrahepatic cholangiocarcinoma

Low Expression of WW Domain‐containing Oxidoreductase Associates with Hepatocellular Carcinoma Aggressiveness and Recurrence after Curative Resection

Loss of Wwox Drives Metastasis in Triple-Negative Breast Cancer by JAK2/STAT3 Axis

Relationship between promoter methylation status and protein expression of the wwox gene in hepatocellular carcinoma

Expression of Wntless in non-special type of invasive ductal carcinoma of breast and its significance

Expression and Invasion of WWOX and P53 Gene in Large Intestine Carcinoma Tissue and Their Relationship with Tumor Infiltration

The Low Expression of MEOX2 is Associated With Poorer Survival in Breast Cancer

WWOX Polymorphisms as Predictors of the Biochemical Recurrence of Localized Prostate Cancer after Radical Prostatectomy

Supplementary Figures S1-S2 from Wwox Suppresses Prostate Cancer Cell Growth Through Modulation of ErbB2-Mediated Androgen Receptor Signaling

Low expression of MEOX2 is associated with poor survival in patients with breast cancer.

WWOX Suppresses Cell Growth and Induces Cell Apoptosis Via Inhibition of P38 Nuclear Translocation in Cholangiocarcinoma

Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors.

The Expression and Clinical Significance of WWOX and FHIT in Colorectal Cancer

Remote Modulation of WWOX by an Intronic Variant Associated with Survival of Chinese Gastric Cancer Patients.